Get started
Author

Eduard Rousel

Observed name: E. Rousel
OpenAlex ID: A5083300299
Impact of metastasectomy on cancer specific and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry
2020 · M.F. Meagher, M. Mir, et al. · European Urology Open Science · 2
Does presence of bone metastases portend worsened prognosis in metastatic renal cell carcinoma? Analysis of the REMARCC (Registry of MetAstatic RCC) database.
2020 · Aaron Bradshaw, Maria Carmen Mir, et al. · Journal of Clinical Oncology · 1
Impact of metastasectomy on progression free and overall survival in metastatic renal cell carcinoma: Analysis of the REMARCC registry.
2020 · Margaret Frances Meagher, Ricardo Autorino, et al. · Journal of Clinical Oncology · 1
Cytoreductive Nephrectomy in Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis of the Remarcc Registry
2024 · Margaret Frances Meagher, Cesare Saitta, et al. · Urologic Oncology Seminars and Original Investigations
Pd18-01 Cytoreductive Nephrectomy in Patients Receiving Tki Therapy Versus Immune Checkpoint Inhibitor Therapy: Analysis of the Remarcc Registry
2022 · Margaret Meagher, Andrea Minervini, et al. · The Journal of Urology
Cytoreductive nephrectomy in patients receiving TKI therapy versus immune checkpoint inhibitor therapy: Comparative outcome analysis of the REMARCC registry
2021 · M.F. Meagher, A. Minervini, et al. · European Urology
Is presence of vena caval thrombosis in primary tumor associated with worsened outcomes in metastatic renal cell carcinoma: Analysis of the REMARCC registry
2021 · M.F. Meagher, M. Mir, et al. · European Urology
Predictors of complications after cytoreductive nephrectomy in the immunotherapy era: Results from a multicenter international study
2021 · M. Marchioni, G. Rebez, et al. · European Urology
Proposal for a two-tier re-classification of stage IV/M1 renal cell carcinoma into M1 (oligometastatic) and M2 (polymetastatic) sub stages
2020 · M.F. Meagher, M. Mir, et al. · European Urology Open Science
Open versus minimally invasive cytoreductive nephrectomy (CN) for metastatic renal cell carcinoma (mRCC): Results from a multicenter retrospective study
2019 · M. Mir, R. Campi, et al. · European Urology Supplements
Mp25-12 Predictors of Major Complications After Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma: Insights From a Retrospective Multicentre Registry
2019 · Riccardo Campi*, Maximilian C. Kriegmair, et al. · The Journal of Urology
Does presence of bone metastases portend worsened prognosis in metastatic renal cell carcinoma? Analysis of the REMARCC (REgistry of MetAstatic RCC) database
2019 · A. Bradshaw, M.C. Mir, et al. · European Urology Supplements
Works count: 12
Citation count: 4
H-index: 1
I10-index:
Year
Topic
Type